Fierce Biotech Fundraising Tracker '26: Cytospire's $83M for TCEs; Vivacta snags $50M+ series A

Fuente: FierceBiotech
The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.
Volver